<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02682576</url>
  </required_header>
  <id_info>
    <org_study_id>A-1601</org_study_id>
    <nct_id>NCT02682576</nct_id>
  </id_info>
  <brief_title>Brachial Artery Ultrasound Imaging: A Repeatability Study</brief_title>
  <official_title>Brachial Artery Ultrasound Imaging: A Repeatability Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Everist Genomics, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Everist Genomics, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to define the analytical repeatability of quantifying
      flow-mediated dilation of the brachial artery using brachial artery ultrasound imaging using
      upper arm cuff occlusion.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline % flow-mediated dilation (%FMD) at 1 hour</measure>
    <time_frame>1 hour</time_frame>
    <description>Repeat brachial artery ultrasound imaging of the same subject after 1 hour using the same operator and vascular ultrasound equipment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of emergent adverse device effects (ADEs) according to CTCAE v4.03</measure>
    <time_frame>1 day</time_frame>
    <description>Spontaneous ADEs reported by the subject and inquiry into emergence of expected/unexpected ADEs</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Brachial artery ultrasound imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brachial artery ultrasound imaging is a non-invasive procedure for detecting endothelial dysfunction by measuring the flow-mediated dilation of the brachial artery using high resolution continuous electrocardiogram-gated B-mode (2D) ultrasound imaging during reactive hyperemia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Brachial artery ultrasound imaging</intervention_name>
    <arm_group_label>Brachial artery ultrasound imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Men and women, ≥18 years old

          2. Eastern Cooperative Oncology Group/Zubrod score performance status of 0, 1, or 2,
             determined within 7 days prior to FMD testing on Study Day 1 (Visit 1)

          3. Written informed consent understood and signed; understanding of study procedures and
             ability to comply with them for the length of the study

        Exclusion Criteria:

          1. Body mass index (BMI) &gt;50 kg/m2

          2. Mid-upper arm circumference of arm selected for FMD testing &lt;17 cm or &gt;42 cm

          3. Sinus arrhythmia (RR intervals vary by &gt;50%), atrial fibrillation, atrial flutter,
             multifocal atrial tachycardia, frequent (&gt;1 per 10-sec strip) premature atrial or
             ventricular contractions (isolated, non-isolated, or alternating), documented by
             12-lead ECG with rhythm strip at the time of subject screening.

          4. Clinical signs and/or symptoms of active viral or bacterial infections

          5. Resting tremor or inability to remain still for the duration of the testing period

          6. Systolic blood pressure (SBP) at rest of &gt;170 mmHg or diastolic blood pressure (DBP)
             at rest of ≥110 mmHg.

          7. Diabetic subjects - Type I or II

          8. Previous intolerable adverse reaction(s) to vascular testing using an upper extremity
             occlusive pneumatic cuff
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter F Lenehan, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Everist Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale University Prevention Research Center</name>
      <address>
        <city>Derby</city>
        <state>Connecticut</state>
        <zip>06418</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2016</study_first_submitted>
  <study_first_submitted_qc>February 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2016</study_first_posted>
  <last_update_submitted>February 6, 2017</last_update_submitted>
  <last_update_submitted_qc>February 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>brachial artery ultrasound imaging</keyword>
  <keyword>flow-mediated dilation</keyword>
  <keyword>endothelium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

